• Symbol Lookup

 
     WELCOME: Guest    LOGIN BECOME A MEMBER

     

Myriad Genetics (MYGN) leaps on upgrade

Tuesday,01 October,2013

Myriad Genetics (NASDAQ: MYGN) surged 10.5% to $25.96. Myriad Genetics reported that CPT code pricing error should take a “week or two” to correct. Ladenburg Thalmann upgraded the stock from neutral to buy. Share volume was 260,000, compared to an all-day average of 1.8 million




                        




            

copyright 1998 - 2014 BayStreet.ca Media Corp. All rights reserved. Nasdaq Stocks: Information delayed 15 minutes. Non-Nasdaq Stocks: Information delayed 20 minutes.
Bid and Ask quotation information for NYSE and AMEX securities is only available on a real time basis. Data is provided by QuoteMedia.com